when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Oncology · news · pharmadog

← back to Oncology

News · Oncology

910 stories

Jul 10, 26Hansoh meets Phase 3 SCLC goal; FDA approves Sanofi on-body injectorendpoints

Jul 10, 26FDA quietly pushes back deadline on electric shock banstat

Jul 10, 26Opinion: The primary care crisis paradoxstat

Jul 9, 26Whistleblower takes on health insurance and FDA commissioner candidatesstat

Jul 9, 26Roche ends work on tominersen after decade of trials, as well as early-stage Huntington’s assetendpoints

Jul 9, 26UK price watchdog recommends against Amgen's Lumakras in lung cancerendpoints

Jul 9, 26Ipsen succeeds in migraine trials; Tarsus buys iRenix for $75M upfrontendpoints

Jul 9, 26STAT+: 931 days. The drug approval scandal hiding in plain sightstat

Jul 8, 26Bryan Johnson’s chronic disease is notoriously difficult to diagnosestat

Jul 8, 26Transplants extended survival for patients whose stage 4 lung cancer hadn’t spread, study saysstat

Jul 8, 26Novartis cuts New Jersey jobs; OTR, LG Chem explore China cancer drugsendpoints

Jul 8, 26STAT+: Pharmalittle: We’re reading about a Vera kidney drug approval, a U.K. Enhertu pricing deal, and morestat

Jul 8, 26Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversalbiopharma dive

Jul 6, 26STAT+: Vertex acquires Crinetics Pharmaceuticals for $10 billion as biotech M&A boomsstat

Jul 6, 26Bristol Myers details Krazati confirmatory study failure in colorectal cancerendpoints

Jul 6, 26Roche aims to bolster breast cancer pipeline with early-stage Astex dealendpoints

Jul 6, 26Gene editing developer Scribe plots an IPObiopharma dive

Jul 6, 26Novartis to acquire ADC developer in a deal worth up to $1.5Bbiopharma dive

Jul 6, 26STAT+: Four major biotech updates to catch up onstat

Jul 6, 26Cancer, immune drugmakers dominate VC funding so far in 2026biopharma dive

Jul 6, 26STAT+: Pharmalittle: We’re reading about a Novartis acquisition, Republicans backing clinical trial diversity, and morestat

Jul 6, 26The race for an Ebola therapy beginsstat

Jul 6, 26Novartis commits $1.1B upfront to take Myricx Bio and its next-gen ADC platformendpoints

Jul 6, 26STAT+: GOP lawmakers push Trump’s FDA to make sure clinical trials are diversestat

Jul 6, 26STAT+: I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learnedstat

Jul 2, 26STAT+: Up and down the ladder: The latest comings and goingsstat

Jul 2, 26STAT+: What does DeGette’s loss mean for pharma?stat

Jul 2, 26Revolution Medicines shares promising data around KRAS drug combinationendpoints

Jul 2, 26Roche KRAS drug succeeds in head-to-head lung cancer studybiopharma dive

Jul 2, 26STAT+: Roche drug sets new standard for KRAS-driven lung cancerstat

← prevpage 14 of 31next →